Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity

DI Cocoș, O Dumitriu Buzia, AL Tatu, M Dinu… - Pharmaceutics, 2024 - mdpi.com
In this study, we focused on innovative approaches to improve drug administration in oral
pathology, especially by transmucosal and transdermal pathways. These improvements …

New insights into the role of the oral leukoplakia microenvironment in malignant transformation

WA González-Arriagada, G Canedo-Marroquin… - Frontiers in Oral …, 2024 - frontiersin.org
Oral leukoplakia is the most frequent and potentially malignant lesion of the oral cavity.
Although dysplasia grading remains the main factor for risk assessment, challenges persist …

Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances

D Jagadeesan, KV Sathasivam, NK Fuloria… - … -Research and Practice, 2024 - Elsevier
Oral squamous cell carcinoma (OSCC) is considered the most common type of head and
neck squamous cell carcinoma (HNSCC) as it holds 90% of HNSCC cases that arise from …

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

S Zhang, X Xiao, Y Yi, X Wang, L Zhu, Y Shen… - … and Targeted Therapy, 2024 - nature.com
Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring
clonal advantage as the initial event. However, despite pervasive somatic mutations and …

A Review of Immunotherapy for Head and Neck Cancer

JW Goetz, G Rabinowits, N Kalman… - Journal of Dental …, 2024 - journals.sagepub.com
The introduction of immune checkpoint inhibitors (ICIs) to oncological care has transformed
the management of various malignancies, including head and neck squamous cell …

Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders

NI Hussein, AH Molina, GM Sunga, M Amit, YL Lei… - Oral Oncology, 2024 - Elsevier
Immunotherapy has developed into an important modality of modern cancer treatment.
Unfortunately, checkpoint inhibitor immunotherapies are currently delivered systemically …

Oral Pre-malignancy: An Update on Novel Therapeutic Approaches

S Naara, C Andrews, A Sikora, M Williams… - Current Oncology …, 2024 - Springer
Abstract Purpose of Review This review aims to provide a comprehensive overview of the
current advances in managing and preventing progression of oral potentially malignant …

[HTML][HTML] A Bibliometric and Visualised Analysis of Proliferative Verrucous Leucoplakia From 2003 to 2023

L Zhu, L Ou, Y Yang, D Zhao, B Liu, R Liu, O Liu… - International Dental …, 2024 - Elsevier
Background Proliferative verrucous leucoplakia (PVL) is a rare but slow-growing, aggressive
leucoplakia lesion associated with the highest malignant transformation rate in oral …

[HTML][HTML] Adhesive lipophilic gels delivering rapamycin prevent oral leukoplakia from malignant transformation

Y Du, T Liu, T Ding, X Zeng, Q Chen, H Zhao - Materials Today Bio, 2024 - Elsevier
Oral leukoplakia (OLK) is the most emblematic oral potentially malignant disorder that may
precede the diagnosis of oral squamous cell carcinoma (OSCC) and has an overall …

Chemoprevention of head and neck cancer: a review of current approaches and future perspectives

S Han, R Bommireddy, P Kim, P Selvaraj… - Cancer Prevention …, 2024 - aacrjournals.org
Head and neck squamous cell carcinoma (HNSCC) is a spectrum of heterogeneous
malignancies. A variety of genetic, environmental, and lifestyle factors contribute to the …